QUANTITATION OF A NOVEL ENGINEERED ANTI-INFECTIVE HOST DEFENSE PEPTIDE, ARV-1502: PHARMACOKINETIC STUDY OF DIFFERENT DOSES IN RATS AND DOGS

Quantitation of a Novel Engineered Anti-infective Host Defense Peptide, ARV-1502: Pharmacokinetic Study of Different Doses in Rats and Dogs

The designer proline-rich antimicrobial peptide (PrAMP) Chex1-Arg20 amide BROW PENCIL (ARV-1502) is active against Gram-negative and Gram-positive pathogens in different murine infection models when administered parenterally and possesses a wide therapeutic index.Here we studied the pharmacokinetics of ARV-1502 for the first time when administered

read more



What are the barriers and facilitators of volunteering among healthcare students during the COVID-19 pandemic? A Saudi-based cross-sectional study

Objectives The objectives of this study were to assess the volunteering of undergraduate health students and interns in the Ministry Field Bib of Health (MOH) services in the Kingdom of Saudi Arabia (KSA) during the COVID-19 pandemic, its motivational factors and barriers, as well as their risk perception of COVID-19.Design A cross-sectional study.

read more